myths

Joe Ravera and Pediatric Small Talk are back with three myths in pediatric emergency medicine.

Welcome to Part II of our evaluation of acute heart failure myths versus facts. This post will look at ED management of heart failure exacerbation.

The LBB should not be used as a therapeutic intervention. Instead, spinal motion restriction should be practiced.

“There are few hard truths in our field, even in this age of evidence-based practice”

Widely-held and taught ideas whose time has passed: Here are eight (!) EM myths from Ryan Dietert, MD.

“Premedication with corticosteroids has never been shown to reduce the risk of moderate or severe adverse drug reactions”

We’re thrilled to present another game-changing writeup from Anand Swaminathan, MD MPH (@EMSwami), this time on the conundrums of shellfish allergies and utility of premedication in patients receiving IV contrast.

“The bolus insulin group had longer lengths of stay and a 6-fold increase in hypoglycemic episodes”

Anand Swaminathan, MD MPH (@EMSwami) addresses urban legends in DKA management, including VBGs vs ABGs, when to replete potassium, bicarb administration, and insulin boluses.

“It’s time to re-examine this recommendation”

Epinephrine in cardiac arrest: helpful for ROSC, but maybe not so much for good neurological outcomes. Anand Swaminathan, MD MPH takes a thought-provoking look at the historical evidence behind this practice, as well as at newer evidence that calls its benefit into question.

“The continued central role [loop diuretics] play highlights a lack of understanding of the underlying pathophysiology of the disease”

In this excellent article, Anand Swaminathan, MD, MPH dissects the evidence to challenge common perceptions regarding the utility of furosemide in patients with APE.